Total value is the twelve-month cost of holding an effective dose, plus whatever oversight comes attached. Eden publishes compounded tirzepatide at $199 a month and separately requires an Eden Membership at $39 for the first month, renewing automatically at $99 a month. Any alternative has to be scored on that same full-year basis, not on a first-month headline.
Establishing which Eden is under discussion
The name is not unique in health care, and several unrelated clinics and benefits companies have used it. The provider examined here is the direct-to-consumer telehealth brand that sells compounded GLP-1 medication at tryeden.com, which currently resolves to eden.health, with the footer entity given as Eden Health International. The domain edenhealth.com did not resolve at the time of writing, so search results that mix the two are common and worth untangling before any figure is trusted.
The two-line invoice is the entire comparison problem
Eden splits its charge in two. The medication price sits on the product page, and the membership sits beside it in a footnote stating that a membership is required, that it does not include or guarantee a prescription, and that medication is not available without one. Read quickly, the page shows $238 a month. Read completely, $238 is the first month only, because the membership steps from $39 to $99 at the second billing cycle.
That structure is legal, disclosed, and increasingly standard. It is also the single most common reason two cash-pay programs that look a dollar apart in month one finish the year hundreds of dollars apart. A provider that bundles the consultation into one medication charge and a provider that bills it separately can be compared only after both are reduced to an annual number.
The arithmetic Eden’s own pages allow
Using only the published figures, a full first year of compounded tirzepatide at Eden works out to $238 for month one and $298 for each of the remaining eleven months, or $3,516. A second year at the standing rate would be $3,576. Nothing in that calculation depends on a promotion or a private quote, and it is the number worth carrying into every other provider’s checkout page.
One genuine strength shows up in the same arithmetic. Eden states a same price at every dose policy, so the figure does not climb when a prescriber moves someone from 2.5 mg to a maintenance strength. Programs that tier by milligram bill their highest rate across the back half of a treatment year, which is exactly when most people are on it.
The field worth naming, and how each one builds a bill
Compounded telehealth is crowded. Hims and Hers, Ro, Henry Meds, Mochi Health and Eden all sell preparations made by compounding pharmacies rather than FDA-approved product. Found operates closer to a coaching and prescribing service and will route people toward branded medication where it is obtainable. Another physician-supervised cash-pay option, FormBlends, publishes flat compounded pricing without a separate platform fee, which makes it a useful structural contrast when working out how much of a rival’s advertised rate is really the medication.
Then there are the manufacturer channels. LillyDirect and NovoCare sell Zepbound and Wegovy respectively at published self-pay rates. Eden itself lists brand pricing alongside its compounded options, quoting $1,399 a month for Zepbound and Mounjaro and $1,695 for Wegovy, which is a useful admission of the gap between the two markets.
| Model | How the bill is assembled | What to confirm before enrolling |
|---|---|---|
| Split medication and membership | Two recurring charges, often on different introductory terms | The renewal rate of the second charge, not the trial rate |
| All-in monthly rate | One charge covering consultation and medication | Whether the rate changes at higher strengths |
| Dose-tiered pricing | Charge rises with each milligram step | The published rate at the strength most patients reach |
| Prepaid multi-month block | Discount in exchange for an upfront commitment | What happens to the unshipped balance on exit |
| Manufacturer self-pay | One drug price, no platform fee | Which strengths are actually stocked at that rate |
| Coaching-led program | Service fee plus whatever the pharmacy charges | Whether medication cost is quoted at all before signup |
Reducing each option to a single annual figure is easier when a provider states its rate plainly rather than in components. Among cash-pay sellers, HealthRX lists its compounded tirzepatide at a published monthly price, Ro and Hims and Hers wrap the consultation into their own structures, Henry Meds sells in multi-month blocks, and manufacturer routes such as LillyDirect quote the branded drug on a separate scale entirely. Lining those figures up on the same twelve-month basis, instead of trusting any one advertised headline, is what turns a scattered field into a decision.
What no price advantage can buy
Compounded tirzepatide is not FDA-approved. The agency does not review compounded preparations for safety or effectiveness, a point Eden discloses in its own product footnotes, and it has published specific concerns about unapproved GLP-1 drugs sold for weight loss. The approved tirzepatide products are narrower and better defined. Mounjaro is labeled as an adjunct to diet and exercise for glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes. Zepbound carries two indications, long-term weight reduction and maintenance in adults with obesity or overweight plus a weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity.
A pharmacovigilance analysis of adverse event reports involving compounded GLP-1 receptor agonists has been published in the peer-reviewed literature, and clinician-facing guidance on compounded semaglutide describes the practical gaps that come with the category. Those are not reasons to dismiss compounded access outright. They are reasons to treat the price difference as the purchase of a different regulatory position rather than a discount on the same item.
Match the evidence to the plan, not to the ad
SURMOUNT-1 studied tirzepatide once weekly in adults with obesity, and SURMOUNT-4 looked specifically at what happens to weight reduction when treatment continues rather than stops. A separate extension of the STEP 1 semaglutide trial measured regain after withdrawal. Those are different molecules and different populations, so they cannot be stacked into a head-to-head result, but together they make one point that belongs in a value calculation: the cost of year two matters as much as the cost of year one, because stopping is not a neutral event.
Frequently asked questions
Is Eden actually cheaper than the alternatives once membership is counted?
Sometimes, and it depends entirely on the comparator. At roughly $3,516 for a first year, it undercuts manufacturer self-pay channels by a wide margin and sits near the middle of the compounded field. Against a flat all-in competitor with no platform fee, the membership can erase the medication price advantage completely.
Does the same price at every dose policy hold across a full year?
Eden states it applies regardless of dosage adjustments during a program, with carve-outs for new member discounts and specific plans. That makes escalation cost-neutral, which is a real advantage over tiered pricing. The carve-out language is worth reading, because promotional plans are the ones most likely to sit outside it.
How should manufacturer channels factor into the decision?
As the benchmark for regulatory standing rather than for price. Zepbound and Mounjaro carry approved labeling, established dosing schedules and an inspected supply chain. Eden’s own site quotes those brands well above its compounded rates, which is the clearest available illustration of what the cash market is actually trading away.
What single figure separates providers fastest?
The total charge in month nine, at the strength most patients reach, including every recurring fee. It forces disclosure of escalation policy, platform fees, prepay conditions and shipment cadence in one answer. Providers whose pricing does not survive that question tend to answer it slowly or not in writing.
Does laboratory testing belong in the comparison?
Yes, and it is frequently missing. Eden’s published plan description covers the provider evaluation, medication, shipping and messaging with a care team, and does not list a bundled laboratory panel. Where testing is not included, the cost sits with the patient through insurance or a cash lab and should be added to the annual figure.
